Advertisement3 Experts Have Resigned From An FDA Committee Over Alzheimer's Drug ApprovalUpdated June 11, 2021Bill ChappellfacebookEmailDr. Aaron Kesselheim (left), a professor at Harvard Medical School, at a documentary film screening in 2018 in Boston. He has resigned from a Food and Drug Administration advisory panel over the FDA's decision to approve an Alzheimer's drug. (AP Images for AIDS Healthcare Foundation)This article was originally published on June 11, 2021.